Hunan Jiudian Pharmaceutical Co Ltd (300705) - Total Liabilities
Based on the latest financial reports, Hunan Jiudian Pharmaceutical Co Ltd (300705) has total liabilities worth CN¥1.28 Billion CNY (≈ $187.09 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 300705 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Hunan Jiudian Pharmaceutical Co Ltd - Total Liabilities Trend (2013–2025)
This chart illustrates how Hunan Jiudian Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 300705 total asset value.
Hunan Jiudian Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hunan Jiudian Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vercom SA
WAR:VRC
|
Poland | zł174.96 Million |
|
Guangdong Hotata Technology Group Co Ltd Class A
SHG:603848
|
China | CN¥658.60 Million |
|
Jiangsu Boiln Plastics Co. Ltd.
SHE:301003
|
China | CN¥94.72 Million |
|
Changzhou Galaxy Century Microelectronics Co Ltd
SHG:688689
|
China | CN¥921.14 Million |
|
Peakstone Realty Trust
NYSE:PKST
|
USA | $1.21 Billion |
|
Elsight Ltd
AU:ELS
|
Australia | AU$13.17 Million |
|
Greenfire Resources Ltd.
NYSE:GFR
|
USA | $165.16 Million |
|
Metals X Limited
F:FG5
|
Germany | €85.98 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Hunan Jiudian Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 300705 net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hunan Jiudian Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hunan Jiudian Pharmaceutical Co Ltd (2013–2025)
The table below shows the annual total liabilities of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.23 Billion ≈ $180.37 Million |
+45.63% |
| 2024-12-31 | CN¥846.40 Million ≈ $123.86 Million |
-5.74% |
| 2023-12-31 | CN¥897.93 Million ≈ $131.40 Million |
+20.20% |
| 2022-12-31 | CN¥747.05 Million ≈ $109.32 Million |
+15.66% |
| 2021-12-31 | CN¥645.90 Million ≈ $94.52 Million |
+118.92% |
| 2020-12-31 | CN¥295.04 Million ≈ $43.17 Million |
-4.90% |
| 2019-12-31 | CN¥310.23 Million ≈ $45.40 Million |
+37.85% |
| 2018-12-31 | CN¥225.05 Million ≈ $32.93 Million |
+106.57% |
| 2017-12-31 | CN¥108.95 Million ≈ $15.94 Million |
+48.02% |
| 2016-12-31 | CN¥73.60 Million ≈ $10.77 Million |
+15.35% |
| 2015-12-31 | CN¥63.81 Million ≈ $9.34 Million |
+8.69% |
| 2014-12-31 | CN¥58.71 Million ≈ $8.59 Million |
-23.06% |
| 2013-12-31 | CN¥76.30 Million ≈ $11.17 Million |
-- |
About Hunan Jiudian Pharmaceutical Co Ltd
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches,… Read more